|
RHOA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.356040E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.567160E-01 |
| Normal-vs-Stage2 |
5.580200E-01 |
| Normal-vs-Stage3 |
9.299400E-01 |
| Normal-vs-Stage4 |
1.428240E-02 |
| Stage1-vs-Stage2 |
7.463400E-01 |
| Stage1-vs-Stage3 |
2.999400E-01 |
| Stage1-vs-Stage4 |
1.538240E-02 |
| Stage2-vs-Stage3 |
6.471000E-01 |
| Stage2-vs-Stage4 |
3.423900E-02 |
| Stage3-vs-Stage4 |
8.180000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.126190E-01 |
| Normal-vs-AfricanAmerican |
4.966400E-01 |
| Normal-vs-Asian |
1.143190E-01 |
| Caucasian-vs-AfricanAmerican |
3.718800E-01 |
| Caucasian-vs-Asian |
1.476030E-01 |
| AfricanAmerican-vs-Asian |
8.256400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.068400E-01 |
| Normal-vs-Female |
1.385900E-02 |
| Male-vs-Female |
2.294100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.361800E-01 |
| Normal-vs-Extreme_Weight |
4.989200E-01 |
| Normal-vs-Obese |
1.062640E-01 |
| Normal-vs-Extreme_Obese |
5.017000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.515200E-01 |
| Normal_Weight-vs-Obese |
4.043900E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.359400E-01 |
| Extreme_Weight-vs-Obese |
3.402000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.261200E-01 |
| Obese-vs-Extreme_Obese |
1.928420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.398000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.266160E-01 |
| Normal-vs-Age(61-80Yrs) |
2.465200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.867200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.945800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.755000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.518400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.245400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.296200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.559800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.997600E-03 |
| Normal-VS-Type2 PRCC |
1.891810E-01 |
| Normal-VS-KIRP CIMP |
9.158000E-01 |
| Normal-VS-Unclassified PRCC |
2.142600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.10149999999976E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.862200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.097800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.541400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.218300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.084600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.039800E-01 |
| Normal-vs-N1 |
5.587900E-02 |
| Normal-vs-N2 |
5.305400E-01 |
| N0-vs-N1 |
3.153000E-01 |
| N0-vs-N2 |
8.614200E-01 |
| N1-vs-N2 |
7.272800E-01 |
|
|
